Clinical Trial Update: Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy and safety of raltegravir in treatment-experienced HIV-1 infected adult Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: HIV | Phase 4 | Status: UNKNOWN